205 related articles for article (PubMed ID: 18723304)
1. [Vaccinations of HIV-infected travelers].
Couzigou C; Voyer C; Shaghaghi CK; Bourée P; Vittecoq D
Med Mal Infect; 2009 Jan; 39(1):21-8. PubMed ID: 18723304
[TBL] [Abstract][Full Text] [Related]
2. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and travel: pretravel recommendations and health-related risks.
Franco-Paredes C; Hidron A; Tellez I; Lesesne J; Del Rio C
Top HIV Med; 2009; 17(1):2-11. PubMed ID: 19270343
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
6. Routine immunization in HIV: helpful or harmful?
Sax P; Singer M
AIDS Clin Care; 1996 Feb; 8(2):11-3, 15. PubMed ID: 11363059
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients.
Donovan RM; Moore E; Bush CE; Markowitz NP; Saravolatz LD
AIDS; 1997 Jul; 11(8):1054-6. PubMed ID: 9223742
[No Abstract] [Full Text] [Related]
8. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.
Veit O; Niedrig M; Chapuis-Taillard C; Cavassini M; Mossdorf E; Schmid P; Bae HG; Litzba N; Staub T; Hatz C; Furrer H;
Clin Infect Dis; 2009 Mar; 48(5):659-66. PubMed ID: 19191654
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
10. The human immunodeficiency virus-infected traveler.
Castelli F; Patroni A
Clin Infect Dis; 2000 Dec; 31(6):1403-8. PubMed ID: 11096010
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
12. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppression and vaccinations].
Débat Zoguéreh D; Ruiz JM
Sante; 2000; 10(3):211-9. PubMed ID: 11022154
[TBL] [Abstract][Full Text] [Related]
14. [Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)].
Wyplosz B; Van der Vliet D; Consigny PH; Calmus Y; Mamzer-Bruneel MF; Guillemain R; Malvy D; Samuel D; Vittecoq D; Launay O;
Med Mal Infect; 2009 Apr; 39(4):225-33. PubMed ID: 19111416
[TBL] [Abstract][Full Text] [Related]
15. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
White A
Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
18. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
20. [Risks and benefits of influenza and pneumococcal immunization in HIV-1 infected individuals].
Tanzi E; Amendola A; Zappa A; Pariani E; Monguzzi A; Colzani D
Ann Ig; 2003; 15(5):567-73. PubMed ID: 14969311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
